University Hospital of Basel
Basel, Canton of Basel-City, 4031, Switzerland
NCT Number: NCT06962501
The primary objectives of this pilot study are to test if a single dose of an oral ketone monoester supplement will increase blood flow and connectivity in the brain in adults with subjective cognitive decline (SCD) or mild cognitive impairment (MCI).
The main questions it aims to answer are:
Does a single dose of an oral ketone supplement increase global cerebral blood flow (CBF)?
Does a single dose of an oral ketone supplement improve resting-state functional connectivity in the Default Mode Network (DMN)?
Does the increase in CBF positively correlate with improved functional connectivity in the DMN?
Participants will:
* Attend one 2-hour session, which includes: * Neurocognitive assessment * MRI Scans (two, each 15 Minutes) * Capillary blood ketone level measurements * Hemodynamic assessment (blood pressure, heart rate)
Looking for future studies?
Notify MeIn this non-randomized, single-arm study participants will undergo a baseline MRI scan to assess functional connectivity in the DMN and resting CBF without ketone supplementation. Participants will then consume 0.3 g/kg body weight of a ketone monoester supplement (∆G Tactical) and then rest for 70 minutes. Participants will then undergo a second MRI scan to evaluate changes in functional connectivity and CBF, with capillary β-OHB and blood pressure measured before and after each scan. The entire experimental visit, including scans and assessments, will last up to 2 hours.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
SCD CRITERIA:
MCI CRITERIA
Exclusion criteria
The oral ketone monoester supplement should increase the global CBF and improve resting-state connectivity in the DMN in adults with SCD or MCI. The participants will take one dose of the supplement followed by measurement, to figure out if there are any noticeable changes.
Time frame: 90 minutes
Functional connectivity of the default mode network (DMN) is measured via functional MRI. Changes in BOLD signal in each region are determined by independent component analysis and then functional connectivity is measured as a Pearson correlation (r) between the neural regions comprising the DMN and transformed into a z score.
Time frame: 90 minutes
Sum of blood flow in the internal carotid and vertebral arteries via phase contrast MRI in ml/min.
Time frame: 90 minutes
Plasma β-OHB will be measured (in millimolar, mM) via finger prick at set intervals before and after supplement ingestion using a handheld commercial analyzer (FreeStyle Libre, Abbott).
Time frame: 90 minutes
Automated blood pressure cuff measurement of brachial artery pressure in mmHg.
Time frame: 90 minutes
Automated blood pressure cuff measurement of heart rate in bpm.
University Department of Geriatric Medicine FELIX PLATTER
Other
The Impact of Acute Oral Ketone Monoester Supplementation on Resting-state Brain Connectivity in Adults With Cognitive Decline
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06746909
Healthy, MCI
Pisa, Italy
View Trial DetailsNCT06335836
AD, Alzheimer Disease
Nanjing, China, Jiangsu, China
View Trial DetailsNCT07630688
Alzheimer Disease, Behavior
Antalya, Muratpaşa, Turkey (Türkiye)
View Trial DetailsNCT07553117
MCI
Bogotá, Colombia
View Trial Details